Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > NR MONDAY

<< Previous

Bullboard Posts

Next >>

Comment by Maxmoeon Feb 12, 2021 12:00am

88 Views

Post# 32549262

RE:RE:RE:NR MONDAY

Will you guys be jibber jabbering about a news release coming any day 3 months from now? Haha. Okay C U Next Tuesday . My niece taught me that one. Makes me laugh every time I hear next Tuesday. hahaha.

Red~One wrote: I can't see them wanting to release good news on a Friday so if they have to wait til Tuesday will the mice stay quiet enough til then?

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta